132 related articles for article (PubMed ID: 38279752)
21. Computed tomography imaging features for amyloid dacryolith in the nasolacrimal excretory system: A case report.
Che ZG; Ni T; Wang ZC; Wang DW
World J Clin Cases; 2021 Mar; 9(8):1940-1945. PubMed ID: 33748245
[TBL] [Abstract][Full Text] [Related]
22. [Prognostic Value of Morphology and Hans Classification in Diffuse Large B Cell Lymphoma].
Wang KL; Chen C; Shi PF; Yu JH; Tan JF; Qian SX; Gao DQ; Chen K; Liu LR; Xie YP; Xu Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Aug; 26(4):1079-1085. PubMed ID: 30111411
[TBL] [Abstract][Full Text] [Related]
23. Distinct molecular profile of IRF4-rearranged large B-cell lymphoma.
Ramis-Zaldivar JE; Gonzalez-Farré B; Balagué O; Celis V; Nadeu F; Salmerón-Villalobos J; Andrés M; Martin-Guerrero I; Garrido-Pontnou M; Gaafar A; Suñol M; Bárcena C; Garcia-Bragado F; Andión M; Azorín D; Astigarraga I; Sagaseta de Ilurdoz M; Sábado C; Gallego S; Verdú-Amorós J; Fernandez-Delgado R; Perez V; Tapia G; Mozos A; Torrent M; Solano-Páez P; Rivas-Delgado A; Dlouhy I; Clot G; Enjuanes A; López-Guillermo A; Galera P; Oberley MJ; Maguire A; Ramsower C; Rimsza LM; Quintanilla-Martinez L; Jaffe ES; Campo E; Salaverria I
Blood; 2020 Jan; 135(4):274-286. PubMed ID: 31738823
[TBL] [Abstract][Full Text] [Related]
24. Viral nucleic acid analysis with PCR in lacrimal tissue and nasal swab samples of primary acquired nasolacrimal duct obstruction cases.
Yanık Ö; Hoşal B; Tekeli A; Nalcı H
Eur J Ophthalmol; 2021 Jan; 31(1):138-143. PubMed ID: 31630558
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathologic and mutational profiles of primary breast diffuse large B cell lymphoma in a male patient: case report and literature review.
Huang F; Ruan Y; He X; Lian H; Yang J
World J Surg Oncol; 2023 Oct; 21(1):342. PubMed ID: 37884941
[TBL] [Abstract][Full Text] [Related]
26. Transformation of Follicular Lymphoma to a High-Grade B-Cell Lymphoma With MYC and BCL2 Translocations and Overlapping Features of Burkitt Lymphoma and Acute Lymphoblastic Leukemia: A Case Report and Literature Review.
Bischin AM; Dorer R; Aboulafia DM
Clin Med Insights Blood Disord; 2017; 10():1179545X17692544. PubMed ID: 28579851
[TBL] [Abstract][Full Text] [Related]
27. Endoscopic endonasal retrieval of a nasolacrimal duct stone via the valve of Hasner in the inferior meatus.
Cnaan RB; Moosajee M; Heatley CJ; Olver JM
Ophthalmic Plast Reconstr Surg; 2012; 28(2):e48-50. PubMed ID: 21743370
[TBL] [Abstract][Full Text] [Related]
28. Indurated Plaques on the Legs: Think Lymphoma.
Watts-Santos A; Cuellar-Barboza A; Ramos-Cavazos CJ; Villarreal-Martinez A; Ocampo-Candiani J; Herz-Ruelas ME
Acta Dermatovenerol Croat; 2021 Jul; 29(2):114-115. PubMed ID: 34477080
[TBL] [Abstract][Full Text] [Related]
29. Large B-cell lymphoma with IRF4 rearrangement-Fine needle biopsy-Report of a case with an atypical presentation.
Barroca H; Marques C; Soares MJ
Diagn Cytopathol; 2023 Nov; 51(11):E322-E327. PubMed ID: 37571800
[TBL] [Abstract][Full Text] [Related]
30. Correlations between BCL6 rearrangement and outcome in patients with diffuse large B-cell lymphoma treated with CHOP or R-CHOP.
Shustik J; Han G; Farinha P; Johnson NA; Ben Neriah S; Connors JM; Sehn LH; Horsman DE; Gascoyne RD; Steidl C
Haematologica; 2010 Jan; 95(1):96-101. PubMed ID: 19797725
[TBL] [Abstract][Full Text] [Related]
31. Nasolacrimal duct orifice cysts in adults: a previously unrecognized, easily treatable cause of epiphora.
DelGaudio JM; Wojno T
Laryngoscope; 2007 Oct; 117(10):1830-3. PubMed ID: 17690605
[TBL] [Abstract][Full Text] [Related]
32. Biallelic BCL6 rearrangements by dual t(3;14)(q27;q32) and t(3;22)(q27;q11) translocations in diffuse large B-cell lymphoma.
Nakamura Y; Itoh Y; Kakegawa E; Uchida Y; Ichimura T; Sasaki A
J Clin Exp Hematop; 2022; 62(4):268-272. PubMed ID: 36575004
[TBL] [Abstract][Full Text] [Related]
33. Treatment of patients with MYC rearrangement positive large B-cell lymphoma with R-CHOP plus lenalidomide: results of a multicenter HOVON phase II trial.
Chamuleau MED; Burggraaff CN; Nijland M; Bakunina K; Mous R; Lugtenburg PJ; Dierickx D; van Imhoff GW; Vermaat JSP; Marijt EAF; Visser O; Mandigers C; Bilgin YM; Beeker A; Durian MF; van Rees B; Bohmer LH; Tick LW; Boersma RS; Snijders TJF; Schouten HC; Koene HR; de Jongh E; Hijmering N; Diepstra A; van den Berg A; Arens AIJ; Huijbregts J; Hoekstra O; Zijlstra JM; de Jong D; Kersten MJ
Haematologica; 2020 Dec; 105(12):2805-2812. PubMed ID: 33256379
[TBL] [Abstract][Full Text] [Related]
34. IRF4/MUM1 expression is associated with poor survival outcomes in patients with peripheral T-cell lymphoma.
Heo MH; Park HY; Ko YH; Kim WS; Kim SJ
J Cancer; 2017; 8(6):1018-1024. PubMed ID: 28529614
[No Abstract] [Full Text] [Related]
35. Expression of MUM1/IRF4 selectively clusters with primary effusion lymphoma among lymphomatous effusions: implications for disease histogenesis and pathogenesis.
Carbone A; Gloghini A; Cozzi MR; Capello D; Steffan A; Monini P; De Marco L; Gaidano G
Br J Haematol; 2000 Oct; 111(1):247-57. PubMed ID: 11091208
[TBL] [Abstract][Full Text] [Related]
36. Nasal dissemination of a single-clone IgH-rearranged conjunctival MALT lymphoma through the nasolacrimal duct: A case report.
Hsieh CY; Liao YP; Wu CC; Yuan SP; Ho JH; Roan R; Liew PL; Lai MT; Lee F
Oncol Lett; 2016 Aug; 12(2):1007-1010. PubMed ID: 27446385
[TBL] [Abstract][Full Text] [Related]
37. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
Plosker GL; Figgitt DP
Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical detection of multiple myeloma 1/interferon regulatory factor 4 (MUM1/IRF-4) in canine plasmacytoma: comparison with CD79a and CD20.
Ramos-Vara JA; Miller MA; Valli VE
Vet Pathol; 2007 Nov; 44(6):875-84. PubMed ID: 18039900
[TBL] [Abstract][Full Text] [Related]
39. CD10, BCL6, and MUM1 expression in diffuse large B-cell lymphoma on FNA samples.
Cozzolino I; Varone V; Picardi M; Baldi C; Memoli D; Ciancia G; Selleri C; De Rosa G; Vetrani A; Zeppa P
Cancer Cytopathol; 2016 Feb; 124(2):135-43. PubMed ID: 26414904
[TBL] [Abstract][Full Text] [Related]
40. Four cycles of R-CHOP followed by two applications of rituximab based on negative interim PET/CT: an analysis of a prospective trial.
Jin J; Ji D; Xia Z; Xue K; Zhang Q; Liu Y; Cao J; Hong X; Gu JJ; Guo Y; Lv F
BMC Cancer; 2022 Apr; 22(1):403. PubMed ID: 35418080
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]